These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 12136628

  • 1. [Drug-induced arrhythmias].
    Mizumaki K, Inoue H.
    Nihon Rinsho; 2002 Jul; 60(7):1449-55. PubMed ID: 12136628
    [Abstract] [Full Text] [Related]

  • 2. [Drug-induced arrhythmias].
    Inoue H.
    Nihon Rinsho; 1996 Aug; 54(8):2220-6. PubMed ID: 8810801
    [Abstract] [Full Text] [Related]

  • 3. Divergent proarrhythmic potential of macrolide antibiotics despite similar QT prolongation: fast phase 3 repolarization prevents early afterdepolarizations and torsade de pointes.
    Milberg P, Eckardt L, Bruns HJ, Biertz J, Ramtin S, Reinsch N, Fleischer D, Kirchhof P, Fabritz L, Breithardt G, Haverkamp W.
    J Pharmacol Exp Ther; 2002 Oct; 303(1):218-25. PubMed ID: 12235254
    [Abstract] [Full Text] [Related]

  • 4. Drug-induced arrhythmias.
    Barnes BJ, Hollands JM.
    Crit Care Med; 2010 Jun; 38(6 Suppl):S188-97. PubMed ID: 20502173
    [Abstract] [Full Text] [Related]

  • 5. Drug-induced QT-interval prolongation and proarrhythmic risk in the treatment of atrial arrhythmias.
    Shantsila E, Watson T, Lip GY.
    Europace; 2007 Sep; 9 Suppl 4():iv37-44. PubMed ID: 17766322
    [Abstract] [Full Text] [Related]

  • 6. Arrhythmias associated with fluoroquinolone therapy.
    Falagas ME, Rafailidis PI, Rosmarakis ES.
    Int J Antimicrob Agents; 2007 Apr; 29(4):374-9. PubMed ID: 17241772
    [Abstract] [Full Text] [Related]

  • 7. Long QT syndrome caused by noncardiac drugs.
    Viskin S, Justo D, Halkin A, Zeltser D.
    Prog Cardiovasc Dis; 2003 Apr; 45(5):415-27. PubMed ID: 12704598
    [Abstract] [Full Text] [Related]

  • 8. Drug-induced q-T prolongation.
    Kao LW, Furbee RB.
    Med Clin North Am; 2005 Nov; 89(6):1125-44, x. PubMed ID: 16227057
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [The pro-arrhythmic effects of anti-arrhythmia agents].
    Haverkamp W, Wichter T, Chen X, Hördt M, Willems S, Rotman B, Hindricks G, Kottkamp H, Borggrefe M, Breithardt G.
    Z Kardiol; 1994 Nov; 83 Suppl 5():75-85. PubMed ID: 7846949
    [Abstract] [Full Text] [Related]

  • 12. [Long QT interval as adverse effect--risk of fatal arrhythmias].
    Bathen J, Spigset O.
    Tidsskr Nor Laegeforen; 2000 Nov 20; 120(28):3432-4. PubMed ID: 11187201
    [No Abstract] [Full Text] [Related]

  • 13. Drug-induced torsade de pointes.
    Raehl CL, Patel AK, LeRoy M.
    Clin Pharm; 1985 Nov 20; 4(6):675-90. PubMed ID: 2416504
    [Abstract] [Full Text] [Related]

  • 14. Drug-induced QT prolongation and proarrhythmia: an inevitable link?
    Ahmad K, Dorian P.
    Europace; 2007 Sep 20; 9 Suppl 4():iv16-22. PubMed ID: 17766320
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Reckless administration of QT interval-prolonging agents in elderly patients with drug-induced torsade de pointes.
    Jackobson G, Carmel NN, Lotan D, Kremer A, Justo D.
    Z Gerontol Geriatr; 2018 Jan 20; 51(1):41-47. PubMed ID: 27878411
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.